
Journal of Medicinal Chemistry p. 49 - 57 (1995)
Update date:2022-07-30
Topics: Synthesis Inhibitory activity Properties Structure-Activity Relationship (SAR) Pharmacokinetics Toxicity and Safety Formulation
Xu
Maga
Focher
Smith
Spadari
Gambino
Wright
Two series of selective inhibitors of herpes simplex virus types 1 and 2 (HSV1,2) thymidine kinases (TK) have been developed as potential treatment of recurrent virus infections. Among compounds related to the potent base analog N2-[m-(trifluor
View MoreBeijing Mashi Fine Chemical Co.,Ltd.
Contact:+86-10-61271592
Address:Room 506, Section B, Kaichi Mansion, Industrial Development
Changzhou Screw International Trading Co., Ltd.
Contact:13906149256,18001495888
Address:Jiangsu,Jintanqu
Hangzhou Zyter Biological & Chemical Technology Co., Ltd.
website:http://www.zyterpharm.com
Contact:+86-18858184290
Address:West Wenyi Road, Cangqian, Yuhang
Chengda Pharmaceuticals Co., Ltd.
Contact:+86-573-84601188
Address:hengshan Road 5# in Jiashan, zhejiang
Jiangsu Hualun Chemical Industry Co., Ltd
website:http://www.hualunchem.com
Contact:+86-0514-86464168 86507985
Address:39# Middle Renmin Road, Dinghuo Town
Doi:10.1039/c4md00082j
(2014)Doi:10.1134/S1068162014030108
(2014)Doi:10.1248/cpb.c13-00518
(2013)Doi:10.1021/jo01270a036
(1968)Doi:10.1248/cpb.42.2575
(1994)Doi:10.1039/c4ra03628j
(2014)